Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Review ArticleClinical Investigation

Pitfalls and Artifacts of 123I-Ioflupane SPECT in Parkinsonian Syndromes: A Quality Improvement Teaching Tool

Cristiane A. Tuma Santos, William David Wallace, Sanghun Kim and Vani Vijayakumar
Journal of Nuclear Medicine Technology June 2021, 49 (2) 114-119; DOI: https://doi.org/10.2967/jnmt.120.258491
Cristiane A. Tuma Santos
Nuclear Medicine Division, Department of Radiology, University of Mississippi Medical Center, Jackson, Mississippi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William David Wallace
Nuclear Medicine Division, Department of Radiology, University of Mississippi Medical Center, Jackson, Mississippi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanghun Kim
Nuclear Medicine Division, Department of Radiology, University of Mississippi Medical Center, Jackson, Mississippi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vani Vijayakumar
Nuclear Medicine Division, Department of Radiology, University of Mississippi Medical Center, Jackson, Mississippi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    (Left) Correct positioning for brain SPECT scan, with head resting in head-and-neck holder and chin in neutral position. (Right) Axial brain SPECT images showing normal findings and no head tilt.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Axial brain SPECT images of 87-y-old woman with parkinsonian features, left-sided weakness, dysarthria, and generalized weakness. Images show head tilt, normal comma shape on left, decreased uptake in right putamen, and dilated ventricles.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Axial brain SPECT images of 67-y-old woman who presented for evaluation of progressive gait instability with falls, micrographia, depth-perception problems, and vertical gaze palsy. Study was nondiagnostic because of increased background uptake from patient’s medications, citalopram and bupropion.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Images of 65-y-old man who had history of low-grade glioma in right midbrain and was being evaluated for right-arm rigidity and tremor. (Left) Axial brain SPECT image showing decreased uptake in right caudate nucleus and no uptake (arrow) in right putamen because of right midbrain glioma. Normal comma-shaped activity is seen in left caudate nucleus and putamen. (Right) Contrast-enhanced T1-weighted brain MR image showing enhancing lesion (arrow) in right midbrain consistent with history of low-grade glioma.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Images of 61-y-old man who had history of infarct in territory of right middle cerebral artery and was being evaluated for right-upper-extremity tremors of 2- to 4-mo duration. (Left) Axial brain SPECT image showing decreased to absent uptake (arrow) in right caudate nucleus and putamen because of prior infarct. (Right) Unenhanced axial CT scan of head showing infarct (arrow).

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Axial brain SPECT images of 80-y-old man on carbidopa–levodopa without improvement of tremors, shuffling gait, and bradykinesia for 2–3 mo. (Left) Images showing decreased uptake bilaterally in putamen and loss of normal comma shape. These findings are scintigraphic evidence of presynaptic-deficit parkinsonian syndrome with probable age-associated changes due to no improvement with medication. (Right) Images showing oversmoothing artifact.

  • FIGURE 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7.

    Axial brain SPECT images of 76-y-old man on primidone with history of resting and action tremors and cogwheel rigidity for 5 y. Images show decreased uptake bilaterally in putamen and right caudate nucleus, with loss of normal comma shape on right and scintigraphic evidence of probable presynaptic-deficit parkinsonian syndrome. Study was limited because of patient’s body habitus and inability to perform SPECT rotation closer to patient's head with required diameter of 11–15 cm.

Tables

  • Figures
    • View popup
    TABLE 1

    Pitfalls in 123I-Ioflupane SPECT

    Pitfall typeDescription
    BiologicDopamine transporter density
    Age
    Sex
    Body habitus
    Ethnicity
    Allelic variants
    Medications competing with dopamine transporter
    Striatal infarct
    Brain tumors
    Trauma
    Surgery
    TechnicalPatient motion
    Patient position
    Patient orientation
    Equipment resolution
    Collimator
    Dose extravasation
    Time after injection
    Photopeak
    Oversmoothing on filtration
    Attenuation correction
    Size and placement of regions of interest
    • Adapted from Morbelli et al. (13).

    • View popup
    TABLE 2

    Effect of Drugs on Striatal 123I-Ioflupane Binding

    Effect typeDrug
    Possible increase in bindingOpioid: fentanyl
    Eugeroic: modafinil
    Antidepressants: bupropion, mazindol, radafaxine
    Anticholinergic: benztropine
    Anesthetics: isoflurane, ketamine, phencyclidine
    Central nervous system stimulant: cocaine
    Possible increase or decrease in bindingAdrenergic agonists: norepinephrine, phenylephrine
    Amphetamines: d-amphetamine, methamphetamine, methylphenidate
    Central nervous system stimulants: ephedrine, phentermine
    No effectDopamine agonists
    N-methyl-d-aspartate receptor blockers
    Monoamine oxidase B inhibitors
    Catechol-O-methyltransferase inhibitors
    • Adapted from Djang et al. (3).

    • View popup
    TABLE 3

    Prescan Withdrawal Time for Drugs That Significantly Affect 123I-Ioflupane SPECT

    DrugWithdrawal time (d)
    Amphetamine7
    Benztropine5
    Bupropion8
    Cocaine2
    Dexamphetamine7
    Mazindol3
    Methylamphetamine3
    Methylphenidate1–2
    Modafinil3
    Phentermine14
    • Adapted from Kägi et al. (6).

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 49 (2)
Journal of Nuclear Medicine Technology
Vol. 49, Issue 2
June 1, 2021
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pitfalls and Artifacts of 123I-Ioflupane SPECT in Parkinsonian Syndromes: A Quality Improvement Teaching Tool
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Pitfalls and Artifacts of 123I-Ioflupane SPECT in Parkinsonian Syndromes: A Quality Improvement Teaching Tool
Cristiane A. Tuma Santos, William David Wallace, Sanghun Kim, Vani Vijayakumar
Journal of Nuclear Medicine Technology Jun 2021, 49 (2) 114-119; DOI: 10.2967/jnmt.120.258491

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pitfalls and Artifacts of 123I-Ioflupane SPECT in Parkinsonian Syndromes: A Quality Improvement Teaching Tool
Cristiane A. Tuma Santos, William David Wallace, Sanghun Kim, Vani Vijayakumar
Journal of Nuclear Medicine Technology Jun 2021, 49 (2) 114-119; DOI: 10.2967/jnmt.120.258491
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • TECHNICAL ARTIFACTS
    • MEDICATION INTERFERENCE
    • PATIENT BIOLOGIC FACTORS
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENT
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Going Nuclear with Amino Acids and Proteins: Basic Biochemistry and Molecular Biology Primer for the Technologist
  • Virtually Celebrating the Advances of Nuclear Medicine and Molecular Imaging: 2021
  • Google Scholar

More in this TOC Section

  • An International Survey Investigating the Incidence and Management of Brown Fat Uptake on 18F-FDG PET/CT at Children’s Hospitals and Interventions for Mitigation
  • A Survey of Patient Experience During Molecular Breast Imaging
  • Safety and Efficacy of 90Y Selective Internal Radiation Therapy Using Glass Microspheres in Hepatocellular Carcinoma: A Southeast Asian Single-Institution Initial Experience
Show more Clinical Investigation

Similar Articles

Keywords

  • Parkinson disease
  • ioflupane
  • SPECT
  • artifacts
  • striatum
  • image quality
SNMMI

© 2025 SNMMI

Powered by HighWire